Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer
Clinical trial NCT04281641 · RECRUITING
Trial details
- NCT number
- NCT04281641
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-21
- Primary completion
- 2025-04-30
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.